Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

Affiliations

• ¹ Headache and Pain Unit, IRCCS San Rafaele Pisana, Rome, Italy. [email protected].
• ² San Rafaele University, Rome, Italy. [email protected].
• ³ Headache and Pain Unit, IRCCS San Rafaele Pisana, Rome, Italy.
• ⁴ Neurology Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
• ⁵ Regional Referral Headache CenterNeurology Unit, University Hospital Tor Vergata, Rome, Italy.
• ⁶ Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
• ⁷ Headache Unit, Department of Neurology, Scientifc Institute San Rafaele Hospital, Vita-Salute University, Via Olgettina, 48, Milan, Italy.
• ⁸ Headache Center, ASST Santi Paolo Carlo, Milan, Italy.
• ⁹ Headache Center, Neurlogy Unit, San Camillo-Forlanini Hospital, Rome, Italy.
• ¹⁰ Neurology Unit, IRCCS San Rafaele Scientifc Institute, Vita-Salute San Raffaele University, Milan, Italy.
• ¹¹ Center for Headache and Intracranial Pressure Disorders, Neurology Unit, A.O.U. Mater Domini, Catanzaro, Italy.
• ¹² Headache and Neurosonology Unit, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
• ¹³ Clinical and Molecular Epidemiology, IRCCS San Rafaele, Roma, Italy.
• ¹⁴ Department of Human Sciences and Quality of Life Promotion, San Rafaele University, Rome, Italy.
• ¹⁵ Headache and Neurosonology Unit, Campus BioMedico University Hospital, Rome, Italy.